Cryptococcus neoformans and Surfactant Protein A
Author Information
Author(s): Giles Steven S., Zaas Aimee K., Reidy Mike F., Perfect John R., Wright Jo Rae
Primary Institution: Duke University Medical Center
Hypothesis
Does surfactant protein A (SP-A) mediate host defense against the pulmonary pathogen Cryptococcus neoformans?
Conclusion
The study found that SP-A does not significantly affect the immune response or disease progression in mice infected with C. neoformans.
Supporting Evidence
- SP-A does not bind to fully encapsulated strains of C. neoformans.
- SP-A binding was detected when C. neoformans was incubated in bronchoalveolar fluid.
- SP-A inhibits IgG-mediated phagocytosis of C. neoformans by alveolar macrophages.
Takeaway
The study shows that a protein called SP-A doesn't help the body fight off a fungus called C. neoformans, which can cause serious lung infections.
Methodology
The study used in vitro binding assays and an intranasal infection model in mice to assess the role of SP-A in host defense against C. neoformans.
Limitations
The study primarily focused on a single strain of C. neoformans and may not generalize to other strains or conditions.
Participant Demographics
Mice used in the study included SP-A deficient and wild-type strains.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website